Women with the GG polymorphism in promoter region of the myeloperoxidase gene G463A have been reported to produce more myeloperoxidase and have a lower possibility of developing cervical cancer than those who have the heterozygous genotype GA24. The gene discussed is MPO; the disease is cervical carcinoma.